RedHill Biopharma Ltd.

2.50
-0.10 (-3.85%)
Apr 02, 2025, 11:44 AM - Market open

RedHill Biopharma Ltd. Stock Forecast

Stock Price Forecast

The 0 analysts with 12-month price forecasts for RDHL stock have an median target of 0, with a low estimate of 0 and a high estimate of 0. The median target predicts a decrease of 0% from the current stock price of 2.50.

Created with Highcharts 11.4.3
Analyst Consensus: Strong Sell
Created with Highcharts 11.4.3Apr 2026$0

Past 12 Months

12 Month Forecast

Target Low Average Median High
Price $0 $0 $0 $0
Change 0% 0% 0% 0%

Latest Analyst Insight Report

According to 0 stock analyst, the rating for RedHill Biopharma Ltd. is "undefined". This means that the analyst believes this stock is likely to lead to similar returns than market as a whole.

Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Total

Financial Forecast this Year

Revenue This Year
20.8M
from 6.51M
Increased by 219.4%
Revenue Next Year
38M
from 20.8M
Increased by 82.7%
EPS This Year
-40
from 3.69
Increased by -984%
EPS Next Year
-10
from -40
Increased by 75.0%